Posted in Other 30+ days ago.
Location: Cambridge, Massachusetts
On January 11, 2021, we announced our intent to separate our severe genetic disease and oncology businesses into differentiated and independent publicly traded companies. We will retain focus on severe genetic disease (SGD) and will launch our oncology business ("Oncology Newco") as a new entity, with the completed transition expected by the end of 2021.
ABOUT THE NEST
At bluebird, only two things matter - patients and our people. When you join the nest, you're not just landing a new gig, you become a part of a flock that's soaring to new heights. We're 1100+ doers, thinkers and collaborators across the globe with a strong sense of our values and our purpose. Our innovation and sustainability are rooted in the diversity of our teams and results are achieved through cooperation and the incorporation of multiple points of view. This is personal and we approach every challenge with radical care. The time is now to rise up and recode the science, the systems, and the status quo.
ABOUT THE FLOCK
The Head of Medical and Scientific Information, Severe Genetic Diseases (SGD), will report to bluebird bio's VP of Medical Affairs and be the primary point person for Medical Information as well as Scientific Information, with the latter broadly encompassing intelligence gathering (from external medical sources and interactions) and internal information dissemination. With two potential, transformative gene therapies launching in the US in the next year and with a third gene therapy potentially launching in the year after that, the incumbent will be responsible for ensuring that our Medical Information function is prepared to handle the anticipated increase in unsolicited medical inquiries through a structured process and with scientifically robust information responses. Furthermore, with the anticipated launches of transformative gene therapies, there will be an elevated importance for intelligence of the evolving therapeutic landscape as well as attention to excellence to ensure our scientific information processes are scalable with a growing team.
As the head of this hybrid function, you will be a key partner with the VP of Medical Affairs, as well as work closely with other medical functions (such as with Scientific Communications, the Medical Directors Office as well as with the Field Medical Affairs team of MSLs). You will primarily oversee the Medical Information function, ensure our medical team is informed of key scientific intelligence pertaining to autologous gene and SGD therapies and help support key tactics for anticipated US launches.
If you are an analytical thinker with strong scientific communication skills, have significant industry experiences in medical affairs and want to be part of the medical team that launches up to three transformative gene therapies in the next few years, look no further...this role is for you so flock on over to check it out!
HOW YOU'LL FLY
As the Head of Medical and Scientific Information, you will report to the VP of Medical Affairs, and help to bring more patients their bluebird days by:
WHAT YOU'LL BRING
You're the bird we're looking for if you have:
All our birds embrace the principles of the bluebird bio culture: b colorful, b cooperative, b yourself.
bluebird bio is deeply committed to fostering an environment where diversity and inclusion are not only valued, but prioritized. We believe a diverse and inclusive community empowers us to act courageously, care deeply, and dream boldly to impact people in big ways. Diverse viewpoints bring diverse capabilities which strengthen our focus and fuel our growth.
bluebird is proud to be an equal opportunity employer, seeking to create a welcoming and diverse environment. All applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, veteran status or any other applicable legally protected characteristics.
Spaulding Hospital-Boston & Cambridge(SRN,SRH,SHC)
|
Cushman & Wakefield
|
Cushman & Wakefield
|
American Bureau of Shipping (ABS)
|
American Bureau of Shipping (ABS)
|
American Bureau of Shipping (ABS)
|